Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in cesarean section
TCTR20241205001Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in nausea ((none)), Vomiting, sponsored by Thammasat University. Started Dec 2024; status: completed.
02
Drugs
nalbuphine
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on TCTR20241205001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241205001.